Breast Cancer Updates From ESMO 2022 Results from the TROPiCS-02, DATA, GIM2, and METEORA-II trials may help inform the treatment of breast cancer.
Cost of Cancer Care Growing for Those With Private Insurance A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
More Than Half of Oncologists Willing to Reduce Initial Dose in Metastatic Setting Survey results reveal whether oncologists are willing to adjust initial drug doses for some patients with metastatic cancer.
Sexual Dysfunction May Be Common Among Women With Cancer In a cohort of nearly 700 women with cancer, more than 60% reported some type of sexual dysfunction.
Chemo Does Not Improve Long-Term Outcomes in Early-Stage ILC Chemotherapy does not improve long-term outcomes in patients with early-stage invasive lobular carcinoma, according to a meta-analysis.
Clinical Trial: Adding Vorinostat to Pembrolizumab and Tamoxifen in ER+ Breast Cancer Publish Date March 20, 2023
Clinical Trial: Valemetostat Plus Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer Publish Date March 20, 2023
Clinical Trial: Tucatinib Plus Alpelisib in PIK3CA-Mutant, HER2+ Breast Cancer Publish Date March 20, 2023
Clinical Trial: CAR-T Cells in Mesothelin-Expressing Triple-Negative Breast Cancer Publish Date March 20, 2023